血脂异常
医学
肠道菌群
疾病
生物群
中医药
血压
冠状动脉疾病
内科学
药理学
生物信息学
重症监护医学
生物
病理
替代医学
生态学
免疫学
作者
Guang Yang,Haoqiang He,Guang Chen,Jie Wang
出处
期刊:PubMed
日期:2020-01-01
卷期号:45 (1): 29-36
被引量:4
标识
DOI:10.19540/j.cnki.cjcmm.20190505.502
摘要
Ischemic heart disease has became the world's most common deadly disease, and coronary heart disease(CHD) is the most common type of ischemic heart disease. The pathological mechanism of CHD has not been fully elucidated. In recent years, scientific studies have found that gut micro-biota are closely related to the occurrence and development of CHD, and CHD could be intervened by regulating gut micro-biota because of the correlation between CHD and intermediate metabolite of gut micro-biota. Current intervention strategies mainly include probiotics supplementation, reduction of TMAO and increase of SCFAs, which can achieve the effect of stabilizing plaques, and controlling blood pressure, blood lipids, blood glucose and obesity. Traditional Chinese medicine(TCM) has the multi-component and multi-target effects, which is correlated to its role in the prevention and treatment of CHD. This paper summarizes the domestic and foreign researches on the effect of TCM in attenuating CHD and its main risk factors by regulating gut micro-biota. The article aims to explore the correlation between gut micro-biota and CHD, and propose three main intervention strategies. Furthermore, the research progress of TCM on CHD, hypertension, dyslipidemia, hyperglycemia and obesity is reviewed by the categories of Chinese medicine monomer and compound, in the hope to provide more theoretical basis for TCM therapy on CHD and guidance for further studies in this field.
科研通智能强力驱动
Strongly Powered by AbleSci AI